by Cara Murez COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease. The treatment, called VV116, worked as well as Paxlovid in people who were at high risk of severe disease in a phase 3 trial in China. The trial was a “great success,” study co-author Ren Zhao, a...
